Venlafaxine treatment of binge-eating disorder associated with obesity: A series of 35 patients

Journal of Clinical Psychiatry

Volumn 63, Issue 9, 2002, Pages 802-806

  Malhotra, Shishuka ^a   King, Karen H ^a   Welge, Jeffrey A ^a   Brusman Lovins, Lori ^a   McElroy, Susan L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; DESIPRAMINE; FLUVOXAMINE MALEATE; PAROXETINE; SERTRALINE; SIBUTRAMINE; VENLAFAXINE;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BINGE EATING DISORDER; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERTENSION; INSOMNIA; MONOTHERAPY; MOOD; NAUSEA; OBESITY; OUTPATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SELF REPORT; SEXUAL DYSFUNCTION; STATISTICAL SIGNIFICANCE; SYMPTOM; TREATMENT PLANNING; WEIGHT REDUCTION; XEROSTOMIA;

EID: 0036737043     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n0909     Document Type: Article

References (38)

1. American Psychiatric Association. Binge-eating disorder. In: Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994:729-731
2. de Zwaan M, Mitchell JE, Raymond NC, et al. Binge-eating disorder: clinical features and treatment of a new diagnosis. Harv Rev Psychiatry 1994;1:310-325
3. Devlin MJ. Eating disorders: assessment and treatment of binge-eating disorder. Psychiatr Clin North Am 1996;19:761-773
4. Fairburn CG, Doll HA, Welch SL, et al. Risk factors for binge-eating disorder: a community-based, case-control study. Arch Gen Psychiatry 1998;55:425-432
5. Agras WS. Treatment of binge-eating disorder. In: Gabbard GD, ed. Treatment of Psychiatric Disorders. Washington, DC: American Psychiatric Press; 2001:2209-2219
6. Spitzer RL, Devlin M, Walsh BT, et al. Binge-eating disorder: a multisite field trial of the diagnostic criteria. Int J Eat Disord 1992;11:191-203
7. Spitzer RL, Yanovski S, Wadden T, et al. Binge-eating disorder: its further validation in a multisite study. Int J Eat Disord 1993;13:137-153
8. Smith DE, Marcus MD, Lewis CE, et al. Prevalence of binge-eating disorder, obesity, and depression in a biracial cohort of young adults. Ann Behav Med 1998;20:227-232
9. Adami GF, Gandolfo P, Bauer B, et al. Binge eating in massively obese patients undergoing bariatric surgery. Int J Eat Disord 1995;17:45-50
10. Saunders R. Binge eating in gastric bypass patients before surgery. Obes Surg 1999;9:72-76
11. Fairburn CG, Cooper Z, Doll HA, et al. The natural course of bulimia nervosa and binge-eating disorder in young women. Arch Gen Psychiatry 2000;57:659-665
12. Hudson JI, Carter WP, Pope HG Jr. Antidepressant treatment of bingeeating disorder: research findings and clinical guidelines. J Clin Psychiatry 1996;57(suppl 8):73-79
13. Hudson JI, McElroy SL, Raymond NC, et al. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled doubleblind trial. Am J Psychiatry 1998;155:1756-1762
14. McElroy SL, Casuto LS, Nelson EB, et al. Sertraline in the treatment of binge-eating disorder: a randomized controlled trial. Am J Psychiatry 2000;157:1004-1006
15. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: a multicenter placebo-controlled, doubleblind trial. Arch Gen Psychiatry 1992;49:139-147
16. Hoffman L, Halmi K. Psychopharmacology in the treatment of anorexia nervosa and bulimia nervosa. Psychiatr Clin North Am 1993;16:767-778
17. Goldstein DJ, Wilson MG, Thompson VL, et al. Long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatry 1995;166:660-666
18. McCann VD, Agras WS. Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study. Am J Psychiatry 1990;147:1509-1513
19. Laederach-Hofmann K, Graf C, Horber F, et al. Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double blind study. Int J Eat Disord 1999;26:231-244
20. Harvey AT, Rudolph RL, Preskom SH. Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry 2000;57:503-509
21. Ferris RM, Cooper BR. Mechanism of antidepressant activity of bupropion. J Clin Psychiatry Monograph 1993;11(1):2-19
22. Horne RL, Ferguson JM, Pope HG Jr, et al. Treatment of bulimia with bupropion: a multicenter controlled trial. J Clin Psychiatry 1988;49:262-266
23. Ryan DH, Kaiser P, Bray GA. Sibutramine: a novel agent for obesity treatment. Obes Res 1995;3(suppl 4):553-559
24. Luque CA, Rey JA. Sibutramine: a serotonin-norepinephrine reuptake inhibitor for the treatment of obesity. Ann Pharmacother 1999;33:968-978
25. Harto-Truax N, Stern WC, Miller LL, et al. Effects of bupropion on body weight. J Clin Psychiatry 1983;44(5 pt 2):183-186
26. Rudolph RL, Fabre LF, Feighner JP, et al. A randomized, placebocontrolled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression. J Clin Psychiatry 1998;59:116-122
27. Gadde KM, Parker CB, Maner LG, et al. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women. Obes Res 2001;9:544-551
28. Thase MT, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001;178:234-241
29. Vollrath M, Koch R, Angst J. Binge eating and weight concerns among young adults: results from the Zurich Cohort Study. Br J Psychiatry 1992; 160:498-503
30. Yanovski SZ, Nelson JE, Dubbert BK, et al. Association of binge-eating disorder and psychiatric comorbidity in obese subjects. Am J Psychiatry 1993;150:1472-1479
31. Hudson JI, Pope HG Jr, Jonas JM, et al. A controlled family history study of bulimia. Psychol Med 1987;17:883-890
32. Walters EE, Neale MC, Eaves LJ, et al. Bulimia nervosa and major depression: a study of common genetic and environmental factors. Psychol Med 1992;22:617-622
33. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders-Research Version (2/96 Final). New York, NY: Biometric Research, New York State Psychiatric Institute; 1996
34. Guy W. ECDEU Assessment Manual for Psychopharmacology, US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976
35. Agras WS, Telch CF, Arnow B, et al. Weight loss, cognitive behavioral, and desipramine treatments in binge-eating disorder: an additive design. Behav Ther 1994;25:225-238
36. Porzelius LK, Houston C, Smith M, et al. Comparison of a standard behavioral weight loss treatment and a binge-eating weight loss treatment. Behav Ther 1995;26:119-134
37. Goodrick GK, Poston WSC II, Kimball KT, et al. Nondieting versus dieting treatment for overweight binge-eating women. J Consult Clin Psychol 1998;66:616-623
38. Devlin MJ, Yanovski SZ, Wilson GT. Obesity: what mental health professionals need to know. Am J Psychiatry 2000;157:854-866